Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: A population-based case-control study

International Journal of Cancer

Volumn 134, Issue 2, 2014, Pages 437-444

  Bodelon, Clara ^a,b   Madeleine, Margaret M ^a,b   Johnson, Lisa G ^a   Du, Qin ^c   Galloway, Denise A ^c,d   Malkki, Mari ^c   Petersdorf, Effie W ^c   Schwartz, Stephen M ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

cervical cancer; nuclear factor B; toll like receptor; tumor necrosis factor; vulvar cancer

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR;

5' UNTRANSLATED REGION; ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CERVICAL ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; LTA GENE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VULVA CANCER;

CERVICAL CANCER; NUCLEAR FACTOR-ΚB; TOLL-LIKE RECEPTOR; TUMOR NECROSIS FACTOR; VULVAR CANCER;

5' UNTRANSLATED REGIONS; ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOTOXIN-ALPHA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NF-KAPPA B; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS; WASHINGTON; YOUNG ADULT;

EID: 84887434715     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28364     Document Type: Article

References (36)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9. (Pubitemid 29406813)
2. De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009; 124: 1626-36.
3. Lindau ST, Drum ML, Gaumer E, et al. Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol 2008; 112: 979-89.
4. Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 2011; 204: 566-73.
5. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907. (Pubitemid 47371147)
6. Magnusson PK, Lichtenstein P, Gyllensten UB,. Heritability of cervical tumours. Int J Cancer 2000; 88: 698-701.
7. Rassa JC, Ross SR,. Viruses and Toll-like receptors. Microbes Infect 2003; 5: 961-8. (Pubitemid 36980849)
8. Akira S, Takeda K,. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511. (Pubitemid 38931765)
9. Baeuerle PA, Henkel T,. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141-79.
10. Aggarwal BB,. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-56. (Pubitemid 41070815)
11. Verstrepen L, Bekaert T, Chau TL, et al. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 2008; 65: 2964-78.
12. Pioli PA, Amiel E, Schaefer TM, et al. Differential expression of Toll-like receptors 2 and 4 in tissues of the human female reproductive tract. Infect Immun 2004; 72: 5799-806. (Pubitemid 39303691)
13. Yan M, Peng J, Jabbar IA, et al. Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-kappaB-mediated signalling, moderated by TGF-beta. Immunol Cell Biol 2005; 83: 83-91. (Pubitemid 40179405)
14. Daud II, Scott ME, Ma Y, et al. Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer 2011; 128: 879-86.
15. Nasu K, Narahara H,. Pattern recognition via the toll-like receptor system in the human female genital tract. Mediators Inflamm 2010; 2010: 976024.
16. Nees M, Geoghegan JM, Hyman T, et al. Papillomavirus Type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kB-responsive genes in cervical keratinocytes. J Virol 2001; 75: 4283-96. (Pubitemid 32410141)
17. Bodelon C, Madeleine MM, Johnson LG, et al. Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study. Gynecol Oncol 2012; 124: 525-8.
18. Hankey BF, Ries LA, Edwards BK,. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999; 8: 1117-21. (Pubitemid 30004912)
19. Madeleine MM, Anttila T, Schwartz SM, et al. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 2007; 120: 650-5. (Pubitemid 44969037)
20. Edlund CK, Lee WH, Li D, et al. Snagger: a user-friendly program for incorporating additional information for tagSNP selection. BMC Bioinformatics 2008; 9: 174.
21. Wigginton JE, Cutler DJ, Abecasis GR,. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 887-93. (Pubitemid 40563110)
22. Yu K, Li Q, Bergen AW, et al. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009; 33: 700-9.
23. Hildesheim A, Wang SS,. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002; 89: 229-40. (Pubitemid 35351541)
24. Madeleine MM, Brumback B, Cushing-Haugen KL, et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 2002; 186: 1565-74. (Pubitemid 35379632)
25. Madeleine MM, Johnson LG, Smith AG, et al. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 2008; 68: 3532-9.
26. Elewaut D, Ware CF,. The unconventional role of LT alpha beta in T cell differentiation. Trends Immunol 2007; 28: 169-75. (Pubitemid 46467519)
27. Vejbaesya S, Luangtrakool P, Luangtrakool K, et al. TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 2009; 199: 1442-8.
28. Randall LM, Kenangalem E, Lampah DA, et al. A study of the TNF/LTA/LTB locus and susceptibility to severe malaria in highland papuan children and adults. Malar J 2010; 9: 302.
29. Morales-Garcia G, Falfan-Valencia R, Garcia-Ramirez RA, et al. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case-control study. BMC Infect Dis 2012; 12: 299.
30. Azevedo ZM, Moore DB, Lima FC, et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) single nucleotide polymorphisms: importance in ARDS in septic pediatric critically ill patients. Hum Immunol 2012; 73: 661-7.
31. Seidemann K, Zimmermann M, Book M, et al. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM 95. J Clin Oncol 2005; 23: 8414-21.
32. Ibrahim A, Abdel Rahman H, Khorshied M, et al. Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt. Leuk Res 2012; 36: 694-8.
33. Wang SS, Bratti MC, Rodriguez AC, et al. Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis 2009; 199: 20-30.
34. Gallicchio L, Chang H, Christo DK, et al. Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington county, Maryland. Am J Epidemiol 2008; 167: 807-13. (Pubitemid 351451746)
35. Oh SS, Chang SC, Cai L, et al. Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. Int J Cancer 2010; 127: 2169-82.
36. Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA,. Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity. PLoS One 2010; 5: e11806.